Dominance of CD8 responses specific for epitopes bound by a single major histocompatibility complex class I molecule during the acute phase of viral infection

Journal of Virology

Volumn 76, Issue 2, 2002, Pages 875-884

  Mothe B R ^a   Horton, H ^a   Carter, D K ^a   Allen, T M ^a   Liebl, M E ^a   Skinner, P ^a   Vogel, T U ^a   Fuenger, S ^a   Vielhuber, K ^a   Rehrauer, W ^a   Wilson, N ^a   Franchini, G ^a   Altman, J D ^a   Haase, A ^a   Picker, L J ^a   Allison, D B ^a   Watkins, D I ^a  

^a UNIVERSITY OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; EPITOPE; GAG PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NEF PROTEIN; PEPTIDE DERIVATIVE; REV PROTEIN; TRANSACTIVATOR PROTEIN; VIF PROTEIN; VPR PROTEIN;

ACUTE PHASE RESPONSE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; IMMUNE RESPONSE; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE CELL; MOLECULAR CLONING; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS INFECTION; VIRUS REPLICATION;

ACUTE DISEASE; ANIMALS; ANTIGENS, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; FLOW CYTOMETRY; GENE PRODUCTS, TAT; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNODOMINANT EPITOPES; LYMPH NODES; MACACA MULATTA; PEPTIDE FRAGMENTS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES, CYTOTOXIC; TIME FACTORS; VIRAL PROTEINS;

EID: 0036138042     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.2.875-884.2002     Document Type: Article

References (40)

1. The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals
2. Tat-specific CTL select for SIV escape variants during resolution of primary viremia
3. Identification of dominant optimal HLA-B60- and HLA-B61-restricted cytotoxic T-lymphocyte (CTL) epitopes: Rapid characterization of CTL responses by enzyme-linked immunospot assay
4. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine
5. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination
6. mac251: Dependence on route of challenge exposure
7. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection
8. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus
9. The MHC class I genes of the rhesus monkey: Different evolutionary histories of MHC class I and II genes in primates
10. The evolving field of HIV CTL epitope mapping: New approaches to the identification of novel epitopes
11. Control of SHIV-89.6P infection of cynomolgus monkeys by HIV-1 Tat protein vaccine
12. HLA and HIV-1: Heterozygote advantage and B*35-Cw*04 disadvantage
13. Protective effects of a live-attenuated SIV vaccine with a deletion in the nef gene
14. Vaccine protection against simian immunodeficiency virus infection
15. Virus-specific CTL responses select for amino acid variation in SIV Env and Nef
16. Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection
17. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS
18. The immunogenetics of human infectious diseases
19. Prolonged clinical latency and survival of macaques given a whole inactivated simian immunodeficiency virus vaccine
20. Dramatic rise in plasma viremia after CD8+ T cell depletion in simian immunodeficiency virus-infected macaques
21. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection
22. ELISPOT assay to detect cytokine-secreting murine and human cells
23. A high frequency of Mamu-A*01 in the rhesus macaque detected by polymerase chain reaction with sequence-specific primers and direct sequencing
24. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome
25. Titration and characterization of two rhesus-derived SIVmac challenge stocks
26. Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques
27. Association of HLA types A1-B8-DR3 and B27 with rapid and slow progression of HIV disease
28. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors
29. Definition of an epitope and MHC class I molecule recognized by gag-specific cytotoxic T lymphocytes in SIVmac-infected rhesus monkeys
30. Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates
31. Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine
32. A formalin-inactivated whole SIV vaccine confers protection in macaques
33. Vaccination with Rev and Tat against AIDS
34. mac-induced immunodeficiency
35. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition
36. The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus
37. Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations
38. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes
39. Cutting edge: In situ tetramer staining of antigen-specific T cells in tissues
40. + lymphocyte response in acutely infected rhesus monkeys